# Boston Scientific Corporation (BSX) — Q3-2024 Earnings Results

**Report date:** 2024-10-23 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q3-2024

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Down 0.64%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.63 | N/A | +7.69% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a cautiously optimistic outlook despite some ongoing challenges. They emphasized their commitment to innovation and market expansion.

**Key quotes:**

> Management highlighted strong performance in key product segments.

> They noted ongoing challenges in the supply chain but expressed confidence in future growth.

### Guidance Changes

No forward guidance was provided during this earnings call.

### What It Means

Boston Scientific reported better-than-expected earnings per share, which indicates strong operational performance. However, the stock reacted negatively, declining by 0.64%. This may reflect investor concerns about the lack of revenue details and guidance, which are critical for assessing future growth prospects.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q3-2024_